132 - Rethinking Breast Cancer Screening on Hormone Therapy: A Fresh Perspective, Part 2

In today's episode we're continuing our conversation about breast cancer surveillance, focusing on the risks of getting a regular mammogram. Last week, we discussed the cumulative risk of radiation damage that women are subjected to over decades of annual mammogram screenings. Mammograms also have shortcomings: they don't detect pre-cancer changes. Many women aren't aware of the unintended harm a regular mammogram can cause. One of those issues is overdiagnosis. This doesn't refer to a false-positive diagnosis, but rather when a mammogram finds a cancer that grows slowly or not at all (which requires no treatment). However, mammograms can't firmly identify these types, so all cancer is treated the same. This means some women enter aggressive treatment when it isn't actually necessary, especially if they are older in age and may not recover well from the treatment they've been recommended. These false-positives can also lead to psychological harm. After the detection of an abnormal finding on a mammogram, women are often sent for additional screening tests (such as a diagnostic breast ultrasound). If this process continues, a woman may also be sent for a biopsy. However, this diagnostic process can take some time—months or even years—and may hurt her mental and emotional wellbeing. 93% of the additional testing required after an abnormal screening mammogram will yield normal, reassuring findings. The chance of false-positives also increases over time. This isn't about dissuading women from getting screened, but it does highlight the importance of exploring screening options.   Connect with Dr. Cernaianu https://www.herabeautyandwellness.com/  https://www.instagram.com/herabeautyandwellness/  https://www.facebook.com/people/Hera-Healthcare-Mirela-Cernaianu-MD/100063462643162/